Targher, Giovanni http://orcid.org/0000-0002-4325-3900
Corey, Kathleen E.
Byrne, Christopher D. http://orcid.org/0000-0001-6322-7753
Roden, Michael http://orcid.org/0000-0001-8200-6382
Article History
Accepted: 25 March 2021
First Online: 10 May 2021
Competing interests
: M.R. is on the scientific advisory boards of Allergan, Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, Gilead Sciences, Inventiva, Intercept Pharma, Novartis, NovoNordisk, Servier Laboratories, Target Pharmasolutions, and Terra Firma and receives investigator-initiated support from Boehringer Ingelheim, Nutricia/Danone and Sanofi–Aventis. K.C. is on the scientific advisory boards for Bristol-Myers Squibb and NovoNordisk and has received grant funding from Boehringer-Ingelheim, Bristol-Myers Squibb and Novartis. G.T. and C.D.B. declare no competing interests.